Literature DB >> 15117909

Reduced uteroplacental blood flow alters renal arterial reactivity and glomerular properties in the rat offspring.

Marijke W Sanders1, Gregorio E Fazzi, Ger M J Janssen, Peter W de Leeuw, Carlos E Blanco, Jo G R De Mey.   

Abstract

Fetal malnutrition and hypoxia may modify organ system maturation and result in cardiovascular diseases in the adult. We tested whether intrauterine stress (IUS) leads to persistent alterations of renal biology. In rats, intrauterine stress was induced by ligation of the uterine arteries at day 17 of pregnancy. Renal arteries of the 21-day-old male offspring were isolated to study pharmacological reactivity. Kidneys were dissected to analyze renal structure and beta-adrenoceptor expression. At 21 days of age, half of the animals underwent unilateral left nephrectomy. At the age of 12 weeks, rats were instrumented for blood pressure monitoring, blood sampling, and renal function measurements. After IUS, litter size and birth weight were reduced, whereas the hematocrit was increased. Renal arterial responses to beta-adrenergic stimulation and sensitivity to adenylyl cyclase activation were increased, along with the renal expression of beta2-adrenoceptors. At 21 days and at 6 months of age, the number and density of the glomeruli were reduced, whereas their size was increased. The filtration fraction and urinary albumin concentration were increased 12 weeks after intrauterine stress. In control rats, removal of the left kidney at 21 days of age did not affect kidney function and blood pressure. However, after IUS, the remaining right kidney failed to compensate for the loss of the left kidney, and blood pressure was increased. In conclusion, prenatal stress transiently modifies renal arterial reactivity and results in long-lasting adverse effects on renal structure and function and on renal compensatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117909     DOI: 10.1161/01.HYP.0000127787.85259.1f

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

Review 1.  Developmental programming of the metabolic syndrome by maternal nutritional imbalance: how strong is the evidence from experimental models in mammals?

Authors:  James A Armitage; Imran Y Khan; Paul D Taylor; Peter W Nathanielsz; Lucilla Poston
Journal:  J Physiol       Date:  2004-09-30       Impact factor: 5.182

Review 2.  Developmental programming of hypertension: insight from animal models of nutritional manipulation.

Authors:  Norma B Ojeda; Daniela Grigore; Barbara T Alexander
Journal:  Hypertension       Date:  2008-05-12       Impact factor: 10.190

3.  Prenatal stress in the rat results in increased blood pressure responsiveness to stress and enhanced arterial reactivity to neuropeptide Y in adulthood.

Authors:  Natalia Igosheva; Paul D Taylor; Lucilla Poston; Vivette Glover
Journal:  J Physiol       Date:  2007-05-10       Impact factor: 5.182

4.  Early renal denervation prevents development of hypertension in growth-restricted offspring.

Authors:  Norma B Ojeda; W Russell Johnson; Terry M Dwyer; Barbara T Alexander
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-11       Impact factor: 2.557

5.  Assessment of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker on the split renal function in the patients with primary hypertension.

Authors:  Jingsi Zhang; Mingyu Wang; Kehui Sun; Yanchun Ding
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

Review 6.  Developmental Programming of Renal Function and Re-Programming Approaches.

Authors:  Eva Nüsken; Jörg Dötsch; Lutz T Weber; Kai-Dietrich Nüsken
Journal:  Front Pediatr       Date:  2018-02-27       Impact factor: 3.418

7.  Prenatal hypoxia inhibited propionate-evoked BK channels of mesenteric artery smooth muscle cells in offspring.

Authors:  Wenna Zhang; Xueqin Feng; Yumeng Zhang; Miao Sun; Lingjun Li; Qinqin Gao; Jiaqi Tang; Pengjie Zhang; Juanxiu Lv; Xiuwen Zhou; Zhice Xu
Journal:  J Cell Mol Med       Date:  2020-01-24       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.